{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T18:37:03Z","timestamp":1768070223334,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.clml.2012.12.002","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T09:19:16Z","timestamp":1358327956000},"page":"273-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Bath-PUVA Therapy Decreases Infiltrating CCR4-Expressing Tumor Cells and Regulatory T Cells in Patients With Mycosis Fungoides"],"prefix":"10.1016","volume":"13","author":[{"given":"Hiroshi","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiyo","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Furuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuzo","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akimichi","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2012.12.002_bib1","series-title":"Rook's Textbook of Dermatology","first-page":"10","article-title":"Cutaneous lymphomas and lymphocytic infiltrates","author":"Whittaker","year":"2010"},{"key":"10.1016\/j.clml.2012.12.002_bib2","series-title":"Dermatology","first-page":"1925","article-title":"Cutaneous T-cell lymphoma","author":"Willemze","year":"2007"},{"key":"10.1016\/j.clml.2012.12.002_bib3","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/archderm.136.4.504","article-title":"Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients","volume":"136","author":"Van Doorn","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clml.2012.12.002_bib4","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/archderm.134.8.949","article-title":"Topical corticosteroids for mycosis fungoides","volume":"134","author":"Zackheim","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clml.2012.12.002_bib5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1346-8138.1990.tb01692.x","article-title":"Treatment of a case of mycosis fungoides and one of parapsoriasis en plaque with topical PUVA using a monofunctional furocoumarin derivative, 4,6,4\u2032-trimethylangelicin","volume":"17","author":"Morita","year":"1990","journal-title":"J Dermatol"},{"key":"10.1016\/j.clml.2012.12.002_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1600-0781.2007.00314.x","article-title":"Narrow-band ultraviolet therapy in early-stage mycosis fungoides: study on 20 patients","volume":"23","author":"Brazzelli","year":"2007","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clml.2012.12.002_bib7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jdermsci.2008.09.011","article-title":"Bath-PUVA therapy induces circulating regulatory T cells in patients with psoriasis","volume":"53","author":"Saito","year":"2009","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clml.2012.12.002_bib8","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1349-7006.2006.00307.x","article-title":"CCR4 as a novel molecular target for immunotherapy of cancer","volume":"97","author":"Ishida","year":"2006","journal-title":"Cancer Sci"},{"key":"10.1016\/j.clml.2012.12.002_bib9","first-page":"3625","article-title":"Clinical significance of CCR4 expression in adult T-cell leukemia\/lymphoma: its close association with skin involvement and unfavorable outcome","volume":"9","author":"Ishida","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clml.2012.12.002_bib10","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-04-0371","article-title":"CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified","volume":"10","author":"Ishida","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clml.2012.12.002_bib11","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/1078-0432.CCR-09-2697","article-title":"Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia\/lymphoma","volume":"16","author":"Ishii","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clml.2012.12.002_bib12","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1200\/JCO.2009.25.3575","article-title":"Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma","volume":"28","author":"Yamamoto","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2012.12.002_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/intimm\/11.1.81","article-title":"Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine","volume":"11","author":"Imai","year":"1999","journal-title":"Int Immunol"},{"key":"10.1016\/j.clml.2012.12.002_bib14","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1067\/mai.2001.113237","article-title":"Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity","volume":"107","author":"Kakinuma","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clml.2012.12.002_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mjd.2003.132","article-title":"Thymus and activation-regulated chemokine (TARC\/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides","volume":"48","author":"Kakinuma","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clml.2012.12.002_bib16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.189.4.711","article-title":"312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions","volume":"189","author":"Ozawa","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.clml.2012.12.002_bib17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1346-8138.1987.tb03601.x","article-title":"Dohi memorial lecture","volume":"14","author":"Edelson","year":"1987","journal-title":"J Dermatol"},{"key":"10.1016\/j.clml.2012.12.002_bib18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jdermsci.2009.03.002","article-title":"Extracorporeal photochemotherapy","volume":"54","author":"Maeda","year":"2009","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clml.2012.12.002_bib19","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1073>3.0.CO;2-R","article-title":"Induction of human tumor-loaded dendritic cells","volume":"91","author":"Berger","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clml.2012.12.002_bib20","doi-asserted-by":"crossref","first-page":"15036","DOI":"10.1074\/jbc.272.23.15036","article-title":"The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4","volume":"272","author":"Imai","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clml.2012.12.002_bib21","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1084\/jem.194.6.847","article-title":"Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells","volume":"194","author":"Iellem","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.clml.2012.12.002_bib22","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/intimm\/dxh165","article-title":"Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells","volume":"16","author":"Yagi","year":"2004","journal-title":"Int Immunol"},{"key":"10.1016\/j.clml.2012.12.002_bib23","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1056\/NEJMra032810","article-title":"The pathogenesis of mycosis fungoides","volume":"350","author":"Girardi","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clml.2012.12.002_bib24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/archderm.1996.03890250052009","article-title":"Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma","volume":"132","author":"Wasik","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clml.2012.12.002_bib25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/00015550510032814","article-title":"Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides","volume":"85","author":"Weber","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clml.2012.12.002_bib26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.imlet.2008.09.003","article-title":"In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules","volume":"121","author":"Nishioka","year":"2008","journal-title":"Immunol Lett"},{"key":"10.1016\/j.clml.2012.12.002_bib27","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.4049\/jimmunol.182.3.1689","article-title":"Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus","volume":"182","author":"Bonelli","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.clml.2012.12.002_bib28","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.clml.2012.12.002_bib29","first-page":"889","article-title":"Crucial role of FOXP3 in the development and function of human CD2+5CD4+ regulatory T cells","volume":"4","author":"Yagi","year":"2004","journal-title":"Int Immunol"},{"key":"10.1016\/j.clml.2012.12.002_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.jid.5700004","article-title":"Regulatory T cells","volume":"126","author":"Beissert","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clml.2012.12.002_bib31","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1038\/sj.leu.2404913","article-title":"FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival","volume":"21","author":"Gjerdrum","year":"2007","journal-title":"Leukemia"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265012002881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265012002881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:24:35Z","timestamp":1761870275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265012002881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S2152265012002881"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2012.12.002","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bath-PUVA Therapy Decreases Infiltrating CCR4-Expressing Tumor Cells and Regulatory T Cells in Patients With Mycosis Fungoides","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2012.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}